PFSCF Stock, Liminal Biosciences Inc - Ordinary Shares Information

Prometic is an established biopharmaceutical company www.prometic.com with widely recognized expertise in bioseparations, plasma derived therapeutics and small molecule therapeutics development. Prometic offers its bioseparation technologies and expertise for large scale purification of biologics, drug development, proteomics and the elimination of pathogens to industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma to develop and commercialize plasma derived therapeutics. Prometic is also active in developing its own novel small molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, targeting, inter alia, the lungs, liver, heart and kidney as well as diabetes, anemia and autoimmune diseases. Headquartered in Laval Canada , Prometic has R amp D facilities in the United Kingdom, the United States and Canada, manufacturing facilities in the UK and Canada and corporate and business development activities in the UK, Canada, USA and Europe. Prometic s common shares trade on the Toronto Stock Exchange TSX under the symbol PLI and the OTCQX International under the symbol PFSCF.